These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7289033)

  • 1. [Sensitivities of clinical isolates to lincomycin and macrolide-type antibiotics (author's transl)].
    Deguchi K
    Jpn J Antibiot; 1981 Mar; 34(3):419-24. PubMed ID: 7289033
    [No Abstract]   [Full Text] [Related]  

  • 2. [Josamycin: antibacterial activity against anaerobes (author's transl)].
    Watanabe K; Watanabe I; Ezaki T; Kobata S; Imamura H; Ninomiya K; Ueno K; Suzuki S
    Jpn J Antibiot; 1978 Aug; 31(8):487-92. PubMed ID: 702806
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antibacterial activities of lincomycin and clindamycin against anerobic bacteria].
    Ninomiya K; Watanabe K; Ueno K; Suzuki S; Mou I
    Jpn J Antibiot; 1973 Apr; 26(2):157-62. PubMed ID: 4354698
    [No Abstract]   [Full Text] [Related]  

  • 4. Cell wall synthesis in Staphylococcus aureus in the presence of protein synthesis inhibitory agents. I. Lincomycin, clindamycin and macrolide antibiotics.
    Nakao M; Kitanaka E; Ochiai K; Nakazawa S
    Jpn J Microbiol; 1972 Sep; 16(5):403-13. PubMed ID: 4539621
    [No Abstract]   [Full Text] [Related]  

  • 5. Resistance to macrolide-lincosamide-streptogramin antibiotics in enterococci from the intestines of animals.
    Dutta GN; Devriese LA
    Res Vet Sci; 1982 Jul; 33(1):70-2. PubMed ID: 6813931
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo induction of resistance to macrolide antibiotics in staphylococci with erythromycin.
    Kurashige S; Inoue M; Yamaguchi N; Mitsuhashi S
    Jpn J Microbiol; 1972 Jan; 16(1):21-5. PubMed ID: 4537712
    [No Abstract]   [Full Text] [Related]  

  • 7. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
    Shadomy S; Tipple M; Paxton L
    Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A mutant of Streptococcus pyogenes 56188 highly resistant to macrolide antibiotics and lincomycin].
    Malke H
    Zentralbl Bakteriol Orig A; 1972 Dec; 222(4):459-67. PubMed ID: 4145163
    [No Abstract]   [Full Text] [Related]  

  • 9. [Changes of antimicrobial susceptibility of anaerobic bacteria from clinical specimens (author's transl)].
    Okada J; Kosakai N; Oguri T
    Jpn J Antibiot; 1975 Dec; 28(6):727-39. PubMed ID: 1042183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
    Kwok YY; Sutter VL; Oberhammer I; Finegold SM
    J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
    [No Abstract]   [Full Text] [Related]  

  • 11. Inducible and constitutive resistance to macrolide antibiotics and lincomycin in clinically isolated strains of Streptococcus pyogenes.
    Hyder SL; Streitfeld MM
    Antimicrob Agents Chemother; 1973 Sep; 4(3):327-31. PubMed ID: 4586147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alteration of 23 S ribosomal RNA and erythromycin-induced resistance to lincomycin and spiramycin in Staphylococcus aureus.
    Lai CJ; Weisblum B; Fahnestock SR; Nomura M
    J Mol Biol; 1973 Feb; 74(1):67-72. PubMed ID: 4731016
    [No Abstract]   [Full Text] [Related]  

  • 13. Resistance of Mycoplasma pneumoniae to macrolide and analogous antibiotics.
    Suzaki K
    Sci Rep Res Inst Tohoku Univ Med; 1979 Dec; 26(3-4):71-91. PubMed ID: 121168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical implications of macrolide resistance and its relationship to the use of tylosin in animal feeds.
    Knothe H
    Infection; 1977; 5(3):137-9. PubMed ID: 914361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of rythromycin on the growth of "dissociated resistant" Staph. aureus in bacteriostasis from another macrolide or a related antibiotic].
    Bourse R; Monnier J
    Ann Inst Pasteur (Paris); 1967 Jul; 113(1):67-79. PubMed ID: 6079710
    [No Abstract]   [Full Text] [Related]  

  • 16. [In vitro antibacterial activity of a new macrolide: miokamycin. Comparison with erythromycin and josamycin].
    Soussy CJ; Leclercq R; Duval J
    Pathol Biol (Paris); 1988 May; 36(5):370-6. PubMed ID: 3043331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Plasmids controlling the resistance to several antibiotics in C. perfringens type A, strain 659].
    Sebald M; Bouanchaud D; Bieth G; Prévot AR
    C R Acad Hebd Seances Acad Sci D; 1975 May; 280(20):2401-4. PubMed ID: 167997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of a new macrolide, A-56268, compared with that of roxithromycin, erythromycin, and clindamycin.
    Barry AL; Thornsberry C; Jones RN
    Antimicrob Agents Chemother; 1987 Feb; 31(2):343-5. PubMed ID: 2952064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of evidence for mutation to erythromycin resistance in clinical strains of Staphylococcus aureus.
    Lacey RW
    J Clin Pathol; 1977 Jul; 30(7):602-5. PubMed ID: 886013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibacterial activity of megalomicin and its inducer activity for macrolide resistance in Staphylococci.
    Saito T; Mitsuhashi S
    J Antibiot (Tokyo); 1971 Dec; 24(12):850-4. PubMed ID: 5140532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.